相关实验视频

Updated: Jul 16, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Published on: June 2, 2022

刺激性肠综合征:同时治疗肠道和大脑/大脑

Maleesha Jayasinghe¹, John A Damianos², Omesh Prathiraja³

¹Medicine, Nanjing Medical University, Nanjing, CHN.

|September 14, 2023

概括

刺激性肠综合征 (IBS) 显著影响生活质量. 本综述详细介绍了包括饮食,运动和心理治疗在内的非药物疗法,作为有效的第一线干预措施来管理IBS症状.

科学领域:

胃肠病学胃肠病学
心理学心理学心理学

背景情况:

刺激性肠综合征 (IBS) 是一种普遍存在的功能性胃肠道疾病,影响全球健康.
对于IBS的发病因子的了解仍然很少,这使管理复杂化,增加了医疗保健负担.
人们越来越认识到IBS是一种复杂的肠-大脑轴障碍,通常与心理并发症同时发生.

研究的目的:

综合审查刺激性肠综合征 (IBS) 的非药物干预措施.
强调个性化治疗策略的重要性,以适应个人IBS症状.
倡导非药理疗法作为主要治疗方法,因为它们具有良好的安全性.

主要方法:

对关于IBS非药物治疗的现有文献进行系统审查.
对各种干预类别的分析,包括饮食,运动,微生物向和心理疗法.
对IBS管理的不同非药理学方法的有效性和适用性进行评估.

主要成果:

非药物治疗为传统IBS治疗提供了安全有效的替代方案或补充.
饮食修改,定期炼,以及诸如认知行为疗法之类的心理干预措施,都显示出显著的症状缓解.
针对微生物群的治疗方法在解决IBS复杂的病理生理学方面表现有前途.

结论:

非药物干预对于管理IBS和改善患者生活质量至关重要.
个性化,多模式的非药物治疗计划应该被认为是IBS的第一线治疗.
对这些干预措施的机制和优化进行进一步的研究是有必要的,以提高IBS护理.

关键词:

对IBS进行诊断.动物食 (Fodmap) 饮食肠-大脑轴肠-大脑轴肠-大脑连接连接 IBS的治疗方法 IBS的治疗方法刺激性肠道疾病是什么刺激性肠综合征 (IBS) 是一种

更多相关视频

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

相关概念视频

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...